DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Hecht JR, Pless M, Cubillo A. et al.
Early safety from a phase I, multicenter, open-label clinical trial of Talimogene laherparepvec (T-VEC) injected (inj) into liver tumors in combination with pembrolizumab (pem).
J Clin Oncol 2020;
38: 3015
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.